Turkmenistan Medical Device Registration: Production Condition and Quality System Evidence

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The preceding chapter clarified the position of ISO 13485 in the dossier; this chapter explains how the three categories of evidence are combined in use. Turkmenistan accepts three categories of evidence for production conditions and the quality system:

  1. Certificates of conformity or declarations of conformity with production condition and product quality requirements;
  2. Certificates that production conditions conform to ISO standard requirements;
  3. The national certificate for the quality control (management) system of medical device production.

The three categories are not a choice of one out of three; they can be stacked and submitted together according to what the manufacturer holds. For most foreign manufacturers the working combination is an ISO 13485 certificate covering the product and site, backed by a manufacturer-issued declaration of conformity for the specific product. Understanding which category each document belongs to, and what each one proves, prevents both duplication and gaps in the dossier, and keeps the quality-system argument legible to a reviewer who is assessing controlled production rather than marketing claims. The stacking order also tells a story: system-level certificates establish the framework, product-level declarations and descriptions fill in the specifics, and together they leave the reviewer without an obvious gap to probe.

2. Legal basis

RegulationReference numberPublication dateProvisions
Law of Turkmenistan on the Supply of MedicinesNo. 319-VJanuary 12, 2016Documentation requirements for national registration
Regulation on State Registration of Medicines and Medical DevicesNo public number (approved by the Ministry of Health)Current versionDocuments describing production conditions and proving conformity with national or international normative documents
Law of Turkmenistan on CertificationNo public number (law)Current versionNational certification system and conformity assessment

3. Expert insights

Insight 1: The declaration of conformity in the first category is the most overlooked and the easiest evidence to obtain.

A declaration of conformity is a statement issued by the manufacturer itself, declaring that the production conditions and product quality conform to specified requirements. It requires no third-party issuance, costs little, and can be produced quickly, which makes it an effective supplement where no ISO certificate exists or where the certificate scope does not cover the product. The declaration should identify the product, the applicable requirements, and the responsible person, and should be signed and dated under the manufacturer’s document control system so that it reads as a controlled record rather than a free-form letter.

Insight 2: The ISO conformity certificate in the second category is the internationally recognized item.

This category corresponds to quality system certificates such as ISO 13485. The decisive factor is the certificate scope: the certified scope must cover the products under application, and the site address on the certificate must match the application form, as explained in the ISO 13485 chapter. Certificates covering sister companies, other product lines, or a different plant address do not carry the argument forward on their own.

Insight 3: The national quality system certificate in the third category points to the Turkmen domestic system.

This category refers to a quality system certificate issued under the national system of Turkmenistan. For foreign manufacturers it is usually not applicable, but its existence is informative: in the design of the Turkmen regulatory system, domestic system certificates and international certificates stand side by side as acceptable evidence. This signals that the framework is conformity-based rather than tied to specific foreign authorities, which is helpful context when arguing the equivalence of ISO evidence.

Insight 4: The question all three categories answer is whether production conditions are controlled.

The overall heading of the dossier item reads: documents describing production conditions and proving that the device conforms to the requirements of national or international normative documents. What the reviewer wants is an evidence chain leading to the conclusion that production conditions are controlled; the three categories of documents are links along that chain. A coherent package therefore pairs system-level evidence with product-level evidence rather than relying on either alone.

Insight 5: The relationship with mandatory TDS certification must be kept distinct.

These three categories are registration-side quality system evidence; mandatory TDS certification is a certification-side conformity assessment, covered in the corresponding chapter of this series. Both involve conformity, but they sit in two systems, two document sets, and two institutional tracks, and the files should be built and archived separately to avoid confusing reviewers and certification bodies alike.

4. Practical recommendations

  1. Use the combination of an ISO 13485 certificate plus a manufacturer declaration of conformity as the baseline package.
  2. Verify the certificate scope and site address verbatim and align them with the application form.
  3. For products not covered by the certificate, supplement with a declaration of conformity listing the applicable standards.
  4. Attach a description of production conditions (processes, key operations, cleanliness class) as supporting material to reinforce the controlled-production argument.
  5. Archive registration-side system evidence and certification-side TDS documents separately and do not mix the files.

5. Verification checklist

  • □ The ISO 13485 certificate plus manufacturer declaration of conformity have been submitted.
  • □ The certificate scope and site address match the application form.
  • □ Products not covered have been supplemented with a declaration of conformity citing the applicable standards.
  • □ A description of production conditions (processes, key operations, cleanliness class) has been attached.
  • □ Registration-side and certification-side documents have been archived separately.

Regulatory information verified as of October 30, 2026. The content cited in this article was cross-checked against the Law of Turkmenistan on the Supply of Medicines No. 319-V of January 12, 2016 and the Regulation on State Registration of Medicines and Medical Devices approved by the Ministry of Health (the three categories of production condition and quality system evidence); the applicability of the national quality system certificate to foreign manufacturers is handled as a practical estimate.

  • GRZAN local resources in Turkmenistan: GRZAN supports manufacturers, importers, and authorized representatives by coordinating licensed local import entities and authorized representative resources, covering national registration submissions, the consular legalization chain for documents, sample delivery, liaison with mandatory TDS certification, and customs clearance support.
  • Service capabilities: classification assessment, registration pathway selection, preparation of dossiers in the approved national formats, consular legalization and notarization, preparation of test and stability documentation, organization of GMP and ISO 13485 evidence, change procedures and certificate renewal, vigilance and post-market maintenance.
  • Contact: info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail